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ABSTRACT 
Background: It is widely recognized that Palliative Radiotherapy  provides effective 
palliation and an improvement in ‘Quality Of Life’ (QOL) in advanced, inoperable head 
and neck malignancies.Various palliative radiation therapy regimens are described in the 
literature, This prospective study  tried  to assess and quantify  symptom relief  and 
duration of symptom relief  in patients with inoperable squamous cell carcinoma of oral 
cavity who underwent a hypofractionated  radiotherapy  with 50Gy in 20 fractions  with 
daily 2.5Gy per fraction daily for four weeks. 
Methods: Between January 2015 and August 2016, seventeen consecutive biopsy proven 
locally advanced inoperable Squamous Cell Carcinoma of the oral cavity patients were 
recruited into the study after getting an informed consent. All of them were planned for 
50 Gy in 20 fractions, 2.5Gy per fraction daily with five fractions per week for a total 
duration of 4 weeks .Patient’s symptoms and quality of life assessment was done before 
starting treatment, after radiation therapy and on first followup with the EORTC QLQ-
C30 & EORTC QLQ - H&N35&EuroQol. Median scores of the individual domains of 
quality of life before treatment, after radiation and in the first follow up with this 
radiation schedule were documented. Statistical Analysis was done using SPSS 17.0 
software. 
Results: Majority of the patients were men (82%) with a median age of 54 years. About 
71% of patients were stage IVA disease. Out of 17 Patients 13 completed 50Gy in 20 
fractions. Two of them discontinued due to personal reasons .In two patients number of 
fractions were cut short due to radiation induced mucositis and poor tolerance. Median 
RT duration was 27days. During the first follow up at 6 weeks, eight patients (57%) had 
partial response and three patients (21.5%) had stable disease while three (21.5%) had 
progressive disease. At the end of the study period, ten patients were alive and 
symptomatically improved and two patients had survival more than 12 months. 
Assessment of change in quality of life over time  showed  functional scales like 
emotional functioning, cognitive functioning and social functioning were found 
significant improvement  at 1% or 5% alpha level (p=0.009, 0.017, 0.016 respectively) 
and  change in Physical and Role functioning scores were significant at 10% alpha level 
(p=0.150, 0.050 respectively). There was significant reduction in pain score. 
Conclusions: Results of our study shows that palliative radiotherapy with 50 Gy in 20 
fractions over 4 weeks is an effective, well tolerated and safe regimen which could 
achieve reasonable palliation with good symptom control and acceptable toxicity profile. 
Statistically significant Quality of life improvement lasting for a minimum six weeks was 
attained after completion of treatment with this regimen. 
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